Oral Tizanidine, an α2-Adrenoceptor Agonist, Reduces the Minimum Alveolar Concentration of Sevoflurane in Human Adults

Authors:
  • ZWZen’iChiro Wajima
    Zen’iChiro Wajima
  • TYTatsusuke Yoshikawa
    Tatsusuke Yoshikawa
  • AOAkira Ogura
    Akira Ogura
  • KIKazuyuki Imanaga
    Kazuyuki Imanaga
  • TSToshiya Shiga
    Toshiya Shiga
  • TITetsuo Inoue
    Tetsuo Inoue
  • RORyo Ogawa
    Ryo Ogawa

Abstract
Y reduced. We speculated that the oral administration of tizanidine might reduce the minimum alveolar anesthetic concentration (MAC) of sevoflurane. Fifty-two ASA physical status I–II patients, aged 24–56 yr, were randomly allocated into two groups: a Control group (n = 26) and a Tizanidine group (n = 26). As premedication, the Control group received a placebo, and the Tizanidine group received 4 mg of oral tizanidine 90 min before surgical skin incision. Anesthesia was induced in all patients by using vital capacity rapid inhaled induction with sevoflurane (5%). Loss of consciousness was defined as both the loss of the eyelid reflex and the lack of a response to a verbal command. MAC was determined by a technique adapted from the conventional up-down method for quantal responses. The MAC of sevoflurane was 2.2% ± 0.2% in the Control group and 1.8% ± 0.2% in the Tizanidine group (P = 0.0004). The time to loss of consciousness in the Tizanidine group (60.2 ± 22.5 s) was significantly shorter than that in the Control group (73.7 ± 26.3 s) (P = 0.03). The oral administration of tizanidine 4 mg successfully reduced the MAC of sevoflurane by 18% in human adults....

This publication has 20 references indexed in Scilit: